Stocks · Healthcare · Biotechnology
Surrozen, Inc. SRZN
$29.13 -0.65% Close, Oct 5, 2026 · NASDAQ · Market cap $219.2M
High qualityExpensive vs sector
Next earnings report: Nov 6, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -385.3% from -205.4% a year earlier.
- The diluted share count rose 171.0% in a year.
- Over the past year the stock returned +111.5%, ahead of the S&P 500 by 95.8 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 20%
- Revenue growth, 3-year CAGRBottom 4%
- Revenue growth accelerationTop 7%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 32%
- Gross marginTop 6%
- Operating marginBottom 19%
- Accruals (lower is better)Top 1%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 3%
- Free-cash-flow yieldBottom 29%
- EBITDA / enterprise valueBottom 1%
- Sales / enterprise valueBottom 29%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 28%
- 6-month returnBottom 48%
- 1-year return vs S&P 500Top 14%
- Distance from 52-week highTop 37%
- Trend checklist (0–4)Top 26%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 34%
- Upside to consensus price targetTop 41%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 2%
- Maximum drawdown, 3 yearsTop 37%
- Beta vs S&P 500 (lower is better)Top 2%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -35.6% | -8.8% | ↑ |
| Gross margin | 100.0% | 99.4% | ↓ |
| Operating margin | -205.4% | -385.3% | ↓ |
| FCF margin | -148.4% | -303.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -8.8% | -35.6% | ↑ | Bottom 20% |
| Gross margin | 99.4% | 100.0% | ↓ | Top 6% |
| Operating margin | -385.3% | -205.4% | ↓ | Bottom 19% |
| Net margin | -2885.3% | -132.3% | ↓ | — |
| Free-cash-flow margin | -303.9% | -148.4% | ↓ | — |
| Return on invested capital | -40.8% | — | Bottom 32% | |
| Revenue growth, 3-year CAGR | -34.7% | — | Bottom 4% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -257.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 60.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +103.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -21.15%
- Shareholder yield
- -21.15%
- Share count change, 1 year
- +171.0%
- Share count change, 3-year CAGR
- +126.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $54.00
- Target vs current price
- +85.4%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 67%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +68.2% | -1.4% | +10.2% | +3.0% | — |
| May 6, 2026 | -738.1% | +4.6% | -6.1% | -24.7% | -32.0% |
| Mar 23, 2026 | -1385.8% | +0.4% | +14.9% | +28.2% | -9.5% |
| Nov 7, 2025 | -614.5% | -2.4% | -3.0% | +63.7% | +89.2% |
| Aug 8, 2025 | +7.3% | +5.9% | +20.2% | +35.1% | +55.0% |
| May 9, 2025 | -581.7% | -3.9% | -21.2% | -2.2% | +19.7% |
| Mar 31, 2025 | -258.3% | +5.9% | -0.2% | -5.7% | -21.0% |
| Nov 6, 2024 | +84.1% | -5.1% | -9.6% | +0.5% | +3.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.41 | -$1.29 | +68.2% | $5.0M |
| May 6, 2026 | -$11.65 | -$1.39 | -738.1% | $5.0M |
| Mar 23, 2026 | -$19.13 | -$1.29 | -1385.8% | $514,000 |
| Nov 7, 2025 | -$8.36 | -$1.17 | -614.5% | $983,000 |
| Aug 8, 2025 | -$1.14 | -$1.23 | +7.3% | $983,000 |
| May 9, 2025 | -$7.43 | -$1.09 | -581.7% | $991,500 |
| Mar 31, 2025 | -$9.10 | -$2.54 | -258.3% | $655,000 |
| Nov 6, 2024 | -$0.44 | -$2.77 | +84.1% | $10.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 10.73× | — | — | Bottom 29% |
| Free-cash-flow yield | -15.96% | — | — | Bottom 29% |
| Earnings yield | -152.04% | — | — | Bottom 3% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 8
- Days above the 200-day average
- 8
- 50-day average slope (20 days)
- +0.0%
- 200-day average slope (20 days)
- +2.1%
- Distance from 50-day average
- +27.1%
- Distance from 200-day average
- +18.5%
- RSI (14)
- 60.7
- Relative volume
- 0.45×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 168.5%
- Volatility vs own 5-year history
- 100th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- -0.09
- Correlation with S&P 500
- -0.01
- Current drawdown from 1-year high
- -14.6%
- Maximum drawdown, 3 years
- -61.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 16, 2021 | Nov 9, 2023 | -97.3% | 541 days | Not yet recovered |
| Jan 29, 2021 | Sep 2, 2021 | -34.5% | 150 days | 8 days (Sep 15, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $219.2M
- EPS, diluted (TTM)
- -$44.29
- Revenue (TTM)
- $11.5M
- 52-week range
- $11.39 – $37.83
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $12.5M | $0 | $10.7M | $3.5M |
| Gross profit | -$3.3M | $9.2M | -$27.2M | $10.7M | $2.9M |
| Operating income | -$54.4M | -$44.3M | -$45.8M | -$25.5M | -$42.1M |
| Net income | -$52.5M | -$36.0M | -$43.0M | -$63.6M | -$242.0M |
| EPS (diluted) | -$23.40 | -$15.55 | -$21.33 | -$21.67 | -$32.37 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.0M | $655,000 | $983,000 | $983,000 | $983,000 | $528,000 | $5.0M | $5.0M |
| Net income | -$1.4M | -$28.0M | -$27.0M | $39.7M | -$71.6M | -$183.2M | -$127.5M | $50.2M |
| EPS (diluted) | -$0.44 | -$8.60 | -$7.43 | $2.55 | -$8.36 | -$23.87 | -$11.65 | -$0.41 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$48.8M | -$44.1M | -$40.4M | -$17.6M | -$30.2M |
| Capital expenditure | -$1.3M | -$728,000 | -$398,000 | -$26,000 | -$128,000 |
| Free cash flow | -$50.1M | -$44.9M | -$40.8M | -$17.7M | -$30.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $124.2M | -$2.6M | $276,000 | $16.0M | $85.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $102.0M
- Total assets
- $115.6M
- Total liabilities
- $334.3M
- Total debt
- $6.3M
- Net debt
- -$95.7M
- Shareholders’ equity
- -$218.7M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 2,195,505
- Days to cover
- 12.68
- Change vs previous report
- +51.9%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Dec 14, 2023
- 1-for-15